This is a full-time position based in London
Apeiron Investment Group builds companies at the very forefront of biotech, spacetech, deep tech, fintech, and crypto.
We’re looking for a driven and structured Associate to build our biotech practice in London. As part of our small, entrepreneurial, and diverse team, you’ll have impact from day one and work on projects that define the global market.
- MD, MBBS, PhD/DPhil or equivalent degree in biological/biomedical sciences or related field
- 3-4 years of experience as an equity analyst at a top-tier investment bank covering biotechnology or analyzing early-stage biotechnology investments in a VC/PE environment
- Strong scientific and financial skillsets
- High professional standard of verbal and written communication
- Embody Apeiron’s values: taking pride in what we do, being impact-driven, building strong relationships, and actively contributing to a positive workplace
- Identify biotech investment opportunities, staying ahead of emerging science, industry trends, challenges and opportunities, regulatory environment, etc.
- Conduct scientific and financial due diligence of investment opportunities, accurately forecasting impact and potential
- Compellingly communicate investment cases and due diligence findings to stakeholders
- Contribute to deal execution including modelling, structuring, negotiating and reporting
- Monitor and manage our existing portfolio
- Maintain and expand networks with a constant eye towards value creation (industry veterans, external advisors, KOL’s, entrepreneurs, and management teams)
- One of the most exciting and unique portfolios in the venture and investment ecosystem
- Profound insights across the full lifecycle of startups and investment deals, from business inception to global capital markets
- An intense learning environment in highly engaged team with investment experience across multiple sectors
- Dynamic, fast-moving, and entrepreneurial company culture valuing fun, diversity, and impact
- Unparalleled professional growth opportunities within our network of portfolio companies
Apeiron Investment Group is led by visionary investor and entrepreneur Christian Angermayer. With an unparalleled global network of advisors, partners, and portfolio companies, we pursue venture investing, turnarounds, and startup incubation all over the world. We pride ourselves in taking an active role in our portfolio companies, and work closely with founders and executive teams to multiply the value of their businesses. Today, our portfolio spans spacetech, biotech, mental health, deep tech, fintech, crypto, leisure, and real estate. Amongst our most well-known investments are ATAI Life Sciences, Compass Pathways, Block.one, Northern Data, Deposit Solutions and Mynaric, all market shapers in their fields.